Physician profile
Wendy Gideon
NPI 1578693297
$1,167.34
in general payments reported to CMS, 2019-2025
12 companies · $55.75 in 2025
The $55.75 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.71 · 2020: $13.45 · 2021: $175 · 2022: $324 · 2023: $295 · 2024: $247 · 2025: $55.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $597.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $600.65 | 2021-2024 | Qelbree, Qelbree |
| Baxter Healthcare | $108.88 | 2022 | |
| Sanofi Pasteur INC. | $92.33 | 2019-2025 | |
| Corium, LLC | $87.32 | 2023-2024 | Azstarys |
| Merck Sharp & Dohme LLC | $58.35 | 2020-2025 | Vaxelis, Vaxneuvance, Rotateq |
| Alk-Abello, INC | $42.84 | 2023 | Odactra, Ragwitek, Grastek |
| Pfizer INC. | $41.71 | 2023-2024 | |
| Cranial Technologies, INC | $38.71 | 2022-2025 | Doc Band |
| Biomerieux INC | $37.71 | 2024 | Biofire Spotfire Respiratory (R) Panel |
| Neos Therapeutics, LP | $22.53 | 2019 | |
| Adlon Therapeutics L.P. | $21.19 | 2021 | |
| Tris Pharma INC | $15.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wendy Gideon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.